Prostate Cancer News on BioPortfolio

Harpoon Therapeutics Expands Board of Directors

Life Sciences Veteran Scott Myers Appointed to the Board of Directors Harpoon Therapeutics Inc. an immunooncology company developing a new class of T cell engaging therapeutics announced today that Scott Myers has joined th...

Genomic Biomarkers in Prostate Cancer

Learn more about the developments in the field of biomarkerbased assays for prostate cancer and learn how they can help guide clinical decisions at each stage of the disease. Translational Andrology and Urology

CANCER de la PROSTATE Ils trouvent la cl de son agressivit

Le cancer de la prostate est le deuxime cancer le plus courant et la cinquime cause de dcs par cancer chez les hommes avec plus de 11 million de nouveaux cas diagnostiqus et 300.000 dcs par an dans le monde. Son mode de dtection de premire ligne le test PS...

Phosphatidylinositol 45 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Phosphatidylinositol 45 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153 Pipeline Review H1 2018 Report Updated 17042018 Prices from USD $350

Phosphatidylinositol 45 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Phosphatidylinositol 45 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153 Pipeline Review H1 2018SummaryPhosphatidylinositol 45 Bisphosphate 3 Kinase...

Pages